Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|July 2, 2026
[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté]Jeanne Longet, Antonia Altmeyer-Figuière, Quentin Jacquinot, et al.
Cancers|June 27, 2024
Exercise Intervention on Insomnia in Patients with a Cancer: A Systematic Review of the LiteratureChloé Drozd, Elsa Curtit, Valérie Gillet, et al.
Breast Cancer Research and Treatment|February 4, 2026
Exercise training decreases Neuregulin-1 concentrations in HER2-positive breast cancer patients undergoing adjuvant trastuzumab: the CARDAPAC studyQuentin Jacquinot, Gaël Ennequin, Antoine Falcoz, et al.
Bulletin Du Cancer|May 11, 2023
[Physical activity in the oncology care pathway: Expectations and perspectives]Aude-Marie Foucaut, Quentin Jacquinot, Thomas Ginsbourger, et al.
Breast Cancer Research and Treatment|February 26, 2026
Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapyChloé Drozd, Elsa Curtit, Quentin Jacquinot, et al.
BMC Cancer|June 21, 2017
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC studyQuentin Jacquinot, Nathalie Meneveau, Marion Chatot, et al.
Frontiers in Oncology|June 14, 2021
Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal AdenocarcinomaChristelle d'Engremont, Julienne Grillot, Julie Raillat, et al.
Breast (Edinburgh, Scotland)|June 19, 2018
Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumabQuentin Jacquinot, Sophie Paget-Bailly, Pierre Fumoleau, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumabQuentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, et al.
BMC Cancer|May 17, 2023
A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN studyChloé Drozd, Elsa Curtit, Quentin Jacquinot, et al.
Pageof 2